Abstract:BACKGROUND: Ketamine is a kind of frequently used general venous anesthesia drug in clinic, and the medication in vein or epidural cavum has analgesic effect. It is N-methyl-D-aspartic acid (NMDA) receptor noncompetitive antagonist, which can inhibit toxic effect of excitatory amino acids. OBJECTIVE: To observe effect of ketamine on apoptosis of dorsal horn astrocytes of spinal cord of rats induced by NMDA receptor over activation and explore its possible mechanism of action. DESIGN: Randomized controlled observation. SETTING: Department of Anesthesiology, Taihe Hospital Affiliated to Yunyang Medical College. MATERIALS: The experiment was conducted at Cell Biology Laboratory, Institute of Basic Medical Sciences, Yunyang Medical College between September 2003 and January 2005. Neonatal Wistar rats of two or three days were provided by Animal Experimental Center of Wuhan University. METHODS: Primary astrocytes in dorsal horn of T11-L6 spinal cord of Wistar rats were purified and cultured. Astrocytes were used in the experiment when its purity coefficient reached 98% assessed by gial fibrillary acidic protein. The cultured cells in 24-well plates were divided randomly into 6 groups (9 portions in each group): ①50 μL Hanks liquor was added into the control group. ②Amount of 100 μmol/L was added into the NMDA group. ③Amount of 1 mmol/L was added into the ketamine group. ④100 μmol/L NMDA + 0.1 mmol/L ketamine group. ⑤100 μmol/L NMDA + 0.5 mmol/L ketamine group. ⑥100 μmol/L NMDA + 1 mmol/L ketamine group. 1 mmol/L ketamine was clinical antalgic dosage. Activity of superoxide dismutase (SOD) and content of malondialdehyde (MDA) were examined after 24-hour culture. Content of Bcl-2 protein and change of morphology were observed with immunocytochemistry. Apoptosis of astrocytes was measured with flow cytometry. MAIN OUTCOME MEASURES: ①Counterstain cell staining and changes of morphology of Bcl-2 protein with immunohistochemical method and hematoxylin-esoin staining (HE). ②Apoptosis of astrocytes was detected with flow cytometry. ③Content of MDA and activity of SOD. RESULTS: ①Mean absorbance (A) of Bcl-2 as expression of Bcl-2 protein measured semiquantitatively: It was lower in the 100 μmol/L NMDA group than the control group, which had significant difference [0.054±0.021, 0.108±0.039, respectively, P < 0.01]. It was higher in the 100 μmol/L NMDA + 1 mmol/L ketamine group than the 100 μmol/L NMDA group, which had significant difference [0.148±0.045, 0.054±0.021, respectively, P < 0.01]. ②Apoptosis of astrocytes detected with flow cytometry: It was higher in the 100 μmol/L NMDA group than the control group, which had significant difference [(25.26±6.13)%,(5.66±2.24)%, respectively, P < 0.01]. It was lower in the 100 μmol/L NMDA + 1 mmol/L ketamine group than in the 100 μmol/L NMDA group, which had significant difference [(24.41±4.82)%,(25.26±6.13)%, respectively, P < 0.01]. ③Content of MDA and activity of SOD: 100 μmol/L NMDA made the content of MDA in astrocytes obviously increase , while the activity of SOD markedly decrease. 1 mmol/L ketamine remarkably decreased the content of MDA, distinctly increased the activity of SOD. This effectiveness had evidently dosage-effect relationship in clinical antalgic dosage, which had obviously difference as compared with that of the NMDA group (P < 0.01). The differences between the 1 mmol/L ketamine group and the control group as well as between the 100 μmol/L NMDA + 0.1 mmol/L ketamine group and the NMDA group had insignificant difference. CONCLUSION: NMDA receptor over activation can induce apoptosis of a great number of astrocytes in spinal dorsal horn of rats. Suitable ketamine dramatically inhibits apoptosis, and its mechanism can enhance the expression of Bcl-2 protein of astrocytes, at the same time inhibit the production of free radical and reinforce the activity of SOD.

Inhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level?

Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain

Combining Ketamine with Astrocytic Inhibitor As a Potential Analgesic Strategy for Neuropathic Pain Ketamine, Astrocytic Inhibitor and Pain.

Effects of ketamine on spinal nerve ligation-induced neuropathic pain

Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain.

EFFECT OF KETAMINE ON SPINAL ASTROCYTES IN RATS FOLLOWING SPINAL NERVE LIGATION

Neuronal NR2B-containing NMDA Receptor Mediates Spinal Astrocytic C-Jun N-terminal Kinase Activation in a Rat Model of Neuropathic Pain

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

The Effects of an Intraperitoneal Single Low Dose of Ketamine in Attenuating the Postoperative Skin/muscle Incision and Retraction-Induced Pain Related to the Inhibition of N-methyl-d-aspartate Receptors in the Spinal Cord

Astrocytic Pyruvate Dehydrogenase Kinase-Lactic Acid Axis Involvement in Glia-Neuron Crosstalk Contributes to Morphine-Induced Hyperalgesia in Mice

Ketamine reduces aversion in rodent pain models by suppressing hyperactivity of the anterior cingulate cortex

The potent analgesia of intrathecal 2R, 6R-HNK via TRPA1 inhibition in LF-PENS-induced chronic primary pain model

Ketamine Potentiates the Effect of Electroacupuncture on Mechanical Allodynia in a Rat Model of Neuropathic Pain

The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats

Influence of ketamine on astrocyte damage in spinal dorsal horn of rats induced by N-methyl-D-aspartic acid

Behavioral and Morphological Evidence for the Involvement of Glial Cells in the Antinociceptive Effect of Najanalgesin in A Rat Neuropathic Pain Model

Low-dose Ketamine Inhibits Expression of P2X4 Receptor in Spinal Dorsal Horn of Rats with Chronic Neuropathic Pain

Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain

Small-dose Ketamine Inhibit the Expression of P2X4 Receptor in Cerebral Cortex of the Rats with Chronic Neuropathic Pain

Effect and Underlying Mechanisms of Spirocyclopiperazinium Salt Compound DXL-A-24 in Rats Following Spinal Nerve Ligation.

A Peptide C-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance